Medicines Help Heart Attack Survivors
Medicines Help Heart Attack Survivors
Cardiovascular Drugs May Help Heart Attack Survivors Live Longer, Study Shows
March 25, 2008 -- Heart attack patients aged 65 and older could prolong their lives by filling their cardiovascular drug prescriptions.
That's the bottom line from a new study of 21,484 Medicare patients in New Jersey and Pennsylvania who had a heart attack between 1995 and 2004.
Video: CholesterolGuidelines
Video: Young Peopleand Heart Disease
Video: PredictingHeart Disease
All Heart-RelatedVideos
Related to heart health
coronary artery disease, angina, atherosclerosis, clogged arteries, cardiovascular disease, chest pain, heart attack, heart disease, myocardial infarction, bypass surgery, angiogram, angioplasty, anger and heart disease , aspirin therapy, stents, EKG
© 2008 WebMD, LLC. All rightsreserved.
The heart attack survivors were 80 years old, on average. They were followed through 2004, beginning a month after their heart attack.
A total of 12,142 patients died during that time. The study doesn't show their causes of death, though many patients were known to have coronary artery disease, heart failure, diabetes, and other serious conditions.
People who received and filled post-heart attack prescriptions for statins, beta-blockers, ACE inhibitors, ARBs, or antiplatelet drugs (not including aspirin) were less likely to die during the study.
After considering other factors, the researchers conclude that use of those prescription drugs trimmed mortality rates by 3% per year from 1995 to 2004.
"These data should encourage clinicians to continue use of these proven therapies in the management of elderly patients after myocardial infarction [heart attack]," write the researchers, who included Soko Setoguchi, MD, DrPH, of Boston's Brigham and Women's Hospital and Harvard Medical School.
The study has some limits. For instance, Setoguchi's team notes that heart attack survivors who filled their prescriptions may have had other advantages, such as healthy lifestyles, and may not have been typical patients.
But the findings, though "largely circumstantial, are nevertheless compelling and consistent" with other research, states an editorial published with the study in the Journal of the American College of Cardiology's April 1 edition.
The editorialists included William Boden, MD, FACC, of the University of Buffalo Schools of Medicine and Public Health.
After Heart Attack, Don’t Brush Off Medication
Cardiovascular Drugs May Help Heart Attack Survivors Live Longer, Study Shows
March 25, 2008 -- Heart attack patients aged 65 and older could prolong their lives by filling their cardiovascular drug prescriptions.
That's the bottom line from a new study of 21,484 Medicare patients in New Jersey and Pennsylvania who had a heart attack between 1995 and 2004.
Heart Health Videos
Video: CholesterolGuidelines
Video: Young Peopleand Heart Disease
Video: PredictingHeart Disease
All Heart-RelatedVideos
Related Slideshows
Related to heart health
coronary artery disease, angina, atherosclerosis, clogged arteries, cardiovascular disease, chest pain, heart attack, heart disease, myocardial infarction, bypass surgery, angiogram, angioplasty, anger and heart disease , aspirin therapy, stents, EKG
© 2008 WebMD, LLC. All rightsreserved.
The heart attack survivors were 80 years old, on average. They were followed through 2004, beginning a month after their heart attack.
A total of 12,142 patients died during that time. The study doesn't show their causes of death, though many patients were known to have coronary artery disease, heart failure, diabetes, and other serious conditions.
People who received and filled post-heart attack prescriptions for statins, beta-blockers, ACE inhibitors, ARBs, or antiplatelet drugs (not including aspirin) were less likely to die during the study.
After considering other factors, the researchers conclude that use of those prescription drugs trimmed mortality rates by 3% per year from 1995 to 2004.
"These data should encourage clinicians to continue use of these proven therapies in the management of elderly patients after myocardial infarction [heart attack]," write the researchers, who included Soko Setoguchi, MD, DrPH, of Boston's Brigham and Women's Hospital and Harvard Medical School.
The study has some limits. For instance, Setoguchi's team notes that heart attack survivors who filled their prescriptions may have had other advantages, such as healthy lifestyles, and may not have been typical patients.
But the findings, though "largely circumstantial, are nevertheless compelling and consistent" with other research, states an editorial published with the study in the Journal of the American College of Cardiology's April 1 edition.
The editorialists included William Boden, MD, FACC, of the University of Buffalo Schools of Medicine and Public Health.
Source...